Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2025-12-24 @ 9:18 PM
NCT ID: NCT03598504
Eligibility Criteria: Inclusion Criteria: * Male and females between ages 18-85 years of age * SCI ( ≥1 month of injury) * ASIA A, B,C and D * SCI above L5 * Able to perform a visible contraction with dorsiflexor and hip flexor muscles (allowing testing of largely impaired patients) * Able to ambulate a few steps with or without an assistive device. Inclusion criteria for healthy controls: * Male and females between ages 18-85 years * Able to complete precision grips with both hands * Able to complete full elbow flexion-extension with both arms. * Able to walk and complete lower-limb tests with both legs. Exclusion Criteria: * Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease, * Any debilitating disease prior to the SCI that caused exercise intolerance * Premorbid, ongoing major depression or psychosis, altered cognitive status * History of head injury or stroke, * Metal plate in skull * History of seizures * Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants. * Pregnant females, and * Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida or herniated cervical disk. This information will be obtained by self-report.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT03598504
Study Brief:
Protocol Section: NCT03598504